[PLX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 33.76%
YoY- -16.86%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 48 5,390 26,113 3,728 2,362 1,132 764 -84.06%
PBT 968 -5,479 22 0 968 0 179 206.52%
Tax -1,741 -81 -8,765 -161 -27,616 108 20,699 -
NP -9,877 -5,479 9,642 -5,904 -8,913 -8,875 -13,689 -19.47%
Tax Rate 179.86% - 39,840.91% - 2,852.89% - -11,563.69% -
Total Cost 9,925 10,869 16,471 9,632 11,275 10,007 14,453 -22.07%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -20,577.08 -101.65 36.92 -158.37 -377.35 -784.01 -1,791.75 405.27%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -1.07 -0.06 0.11 -0.07 -1.01 -0.10 -0.16 252.91%
EPS Diluted -1.07 -0.06 0.10 -0.07 -1.01 -0.10 -0.16 252.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.